- Home
- MBWM vs OCS Comparison
MBWM vs OCS Comparison
Compare MBWM & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- OCS
- Stock Information
- Founded
- MBWM 1997
- OCS 2003
- Country
- MBWM United States
- OCS Switzerland
- Employees
- MBWM N/A
- OCS N/A
- Industry
- MBWM Major Banks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- MBWM Finance
- OCS Health Care
- Exchange
- MBWM Nasdaq
- OCS Nasdaq
- Market Cap
- MBWM 763.7M
- OCS 869.8M
- IPO Year
- MBWM 1997
- OCS N/A
- Fundamental
- Price
- MBWM $45.12
- OCS $21.09
- Analyst Decision
- MBWM Buy
- OCS Strong Buy
- Analyst Count
- MBWM 4
- OCS 4
- Target Price
- MBWM $53.63
- OCS $41.00
- AVG Volume (30 Days)
- MBWM 59.7K
- OCS 42.4K
- Earning Date
- MBWM 10-21-2025
- OCS 11-06-2025
- Dividend Yield
- MBWM 3.37%
- OCS N/A
- EPS Growth
- MBWM N/A
- OCS N/A
- EPS
- MBWM 5.03
- OCS N/A
- Revenue
- MBWM $228,384,000.00
- OCS $960,668.00
- Revenue This Year
- MBWM $10.34
- OCS $36.75
- Revenue Next Year
- MBWM $11.93
- OCS $1,261.53
- P/E Ratio
- MBWM $8.97
- OCS N/A
- Revenue Growth
- MBWM 3.70
- OCS N/A
- 52 Week Low
- MBWM $37.76
- OCS $14.00
- 52 Week High
- MBWM $52.98
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- MBWM 41.11
- OCS 79.81
- Support Level
- MBWM $44.38
- OCS $17.26
- Resistance Level
- MBWM $46.10
- OCS $17.80
- Average True Range (ATR)
- MBWM 0.86
- OCS 0.58
- MACD
- MBWM -0.08
- OCS 0.38
- Stochastic Oscillator
- MBWM 23.09
- OCS 95.78
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.